Advertisement

Trends in Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery From a Large National Cohort

Published:November 26, 2022DOI:https://doi.org/10.1016/j.urology.2022.11.010

      Abstract

      Objective

      To assess changes in antibiotic prophylaxis for inflatable penile prosthesis surgery following publication of the American Urological Association (AUA) Best Practice Statement in April 2008.

      Materials and Methods

      The Premier Healthcare Database was queried for inflatable penile prosthesis surgeries from January 2000 to March 2020. The primary outcome was administration of an AUA-adherent antimicrobial regimen and secondary outcome was 90-day explant. Piecewise linear regression was used to compare antimicrobial trends before vs after guideline publication. Multivariable logistic regression models were constructed for primary and secondary outcomes.

      Results

      A total of 26,574 patients who underwent inflatable penile prosthesis surgery were identified, of whom 17,754 (67%) received AUA-adherent antibiotics. After guideline publication, there was a 42% relative increase in AUA-adherent regimen usage, with an increase in the usage trend on piecewise linear regression (from 0.1% to 0.8% of encounters per quarter, R2 = 0.75, P < .001). Increased usage trends were also observed for gentamicin (from 0.0% to 1.0% of encounters per quarter, R2 = 0.84, P < .001) and vancomycin (0.1%-0.7%, R2 = 0.77, P < .001). On multivariable regression, odds of AUA-adherence increased after guideline publication (OR: 1.67, 95% CI: 1.54-1.80, P < .001) and with surgery by a high-volume surgeon (OR: 2.21, 95% CI: 2.07-2.35, P < .01). Nonadherence to an AUA-recommended regimen with use of nonstandard antibiotics (OR: 1.16, 95% CI: 0.78-1.71, P = .5) or excess antibiotics (OR: 0.91, 95% CI: 0.62-1.30, P = .6) was not independently associated with increased risk of 90-day explant.

      Conclusions

      Publication of the AUA Best Practice Statement was associated with subsequent increases in the usage of guideline-adherent antibiotic regimens, particularly vancomycin and gentamicin, despite absence of level-1 evidence supporting this combination.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Feldman HA
        • Goldstein I
        • Hatzichristou DG
        • Krane RJ
        • McKinlay JB.
        Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
        J Urol. 1994; 151: 54-61https://doi.org/10.1016/s0022-5347(17)34871-1
        • Bettocchi C
        • Palumbo F
        • Spilotros M
        • et al.
        Patient and partner satisfaction after AMS inflatable penile prosthesis implant.
        J Sex Med. 2010; 7: 304-309https://doi.org/10.1111/j.1743-6109.2009.01499.x
        • Lindeborg L
        • Fode M
        • Fahrenkrug L
        • Sønksen J.
        Satisfaction and complications with the Titan® one-touch release penile implant.
        Scand J Urol. 2014; 48: 105-109https://doi.org/10.3109/21681805.2013.808695
        • Burnett AL
        • Nehra A
        • Breau RH
        • et al.
        Erectile dysfunction: AUA guideline.
        J Urol. 2018; 200: 633
        • Wolf Jr, JS
        • Bennett CJ
        • Dmochowski RR
        • et al.
        Best practice policy statement on urologic surgery antimicrobial prophylaxis.
        J Urol. 2008; 179 ([published correction appears in J Urol. 2008 Nov;180(5):2262-3]): 1379-1390https://doi.org/10.1016/j.juro.2008.01.068
      1. Wolf JS Jr, Bennett CJ, Dmochowski RR, et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis (2012). Published 2008; Reviewed and Validity Confirmed 2011; Amended 2012.

        • Swanton AR
        • Yafi FA
        • Munarriz RM
        • Gross MS.
        A critique of the American Urological Association penile prosthesis antibiotic prophylaxis guidelines.
        J Sex Med. 2021; 18: 1-3https://doi.org/10.1016/j.jsxm.2020.10.010
        • Bonkat G
        • Bartoletti R
        • Bruyère F
        • et al.
        EAU Guidelines on Urological Infections. Electronic Version.
        EAU Guidelines Office, Arnhem, The Netherlands2022 (ISBN 978-94-92671-16-5)
        • Ivan SJ
        • Sindhwani P.
        Comparison of guideline recommendations for antimicrobial prophylaxis in urologic procedures: variability, lack of consensus, and contradictions.
        Int Urol Nephrol. 2018; 50: 1923-1937https://doi.org/10.1007/s11255-018-1971-1
      2. Premier Healthcare Database White Paper: Data that Informs and Performs.
        Premier Applied Sciences®, Premier Inc, 2020 (Available at:)
        • Gross MS
        • Phillips EA
        • Carrasquillo RJ
        • et al.
        Multicenter investigation of the micro-organisms involved in penile prosthesis infection: an analysis of the efficacy of the AUA and EAU guidelines for penile prosthesis prophylaxis.
        J Sex Med. 2017; 14: 455-463https://doi.org/10.1016/j.jsxm.2017.01.007
        • Rezaee ME
        • Towe M
        • Osman MM
        • et al.
        A multicenter investigation examining American Urological Association recommended antibiotic prophylaxis vs nonstandard prophylaxis in preventing device infections in penile prosthesis surgery in diabetic patients.
        J Urol. 2020; 204: 969-975https://doi.org/10.1097/JU.0000000000001158
        • Tobert CM
        • Nepple KG
        • McDowell BD
        • et al.
        Compliance with American Urological Association guidelines for nonmuscle invasive bladder cancer remains poor: assessing factors associated with noncompliance and survival in a rural state.
        Urology. 2019; 132: 150-155https://doi.org/10.1016/j.urology.2019.06.021
        • Davuluri M
        • Bernstein AP
        • Fram E
        • Watts KL.
        Variations in perioperative antibiotic prescriptions among academic urologists after ambulatory endoscopic urologic surgery: impact on infection rates and validation of 2019 Best Practice Statement.
        Urology. 2020; 146: 101-106https://doi.org/10.1016/j.urology.2020.07.049
        • Mossanen M
        • Calvert JK
        • Holt SK
        • et al.
        Overuse of antimicrobial prophylaxis in community practice urology.
        J Urol. 2015; 193: 543-547https://doi.org/10.1016/j.juro.2014.08.107
        • Tanne JH.
        FDA adds “black box” warning label to fluoroquinolone antibiotics.
        BMJ. 2008; 337 (a816. Published 2008 Jul 15)https://doi.org/10.1136/bmj.a816
        • Pederzoli F
        • Chappidi MR
        • Collica S
        • et al.
        Analysis of hospital readmissions after prosthetic urologic surgery in the United States: nationally representative estimates of causes, costs, and predictive factors.
        J Sex Med. 2017; 14: 1059-1065https://doi.org/10.1016/j.jsxm.2017.06.003
        • Kirshenbaum EJ
        • Nelson M
        • Hehemann MC
        • et al.
        Impact of post-hospital syndrome on penile prosthesis outcomes: a period of global health risk.
        J Urol. 2019; 201: 154-159https://doi.org/10.1016/j.juro.2018.08.039